Corcept Therapeutics (CORT) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $116.65 +1.90%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of $0.19, $0.03 better than the analyst estimate of $0.16. Revenue for the quarter came in at $57.7 million versus the consensus estimate of $58.18 million.
GUIDANCE:
Corcept Therapeutics sees Q2 2018 revenue of $275-300 million, versus the consensus of $290.2 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
- L3Harris CEO steps down amid conduct review, shares drop
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
